Sodium-glucose cotransporter 2 inhibitor-induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score-matched model analysis in Japan.
Kazuo KobayashiMasao ToyodaNobuo HatoriTakayuki FurukiHiroyuki SakaiKazuyoshi SatoMasaaki MiyakawaKouichi TamuraAkira KanamoriPublished in: Journal of diabetes investigation (2021)
The degree of blood pressure reduction after SGLT2 inhibitor treatment influenced renal composite outcomes in Japanese type 2 diabetes mellitus patients with CKD, confirming the importance of blood pressure management in type 2 diabetes mellitus patients with CKD, even when they are under SGLT2 inhibitor treatment.